SCHEMBL10028124

SCHEMBL10028124

c1ccc(-c2cc(-c3ccccc3)c3oc4ccc5c(-c6ccccc6)cc(-c6ccccc6)c6oc7ccc2c3c7-c4c56)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 6/20 0.43
CYP1B1 Q16678 5/20 0.43
CYP1A1 P04798 5/20 0.43
MAOB P27338 4/20 0.41
AKR1B1 P15121 2/20 0.41
CA12 O43570 2/20 0.41
CA9 Q16790 2/20 0.41
ALDH2 P05091 1/20 0.41
MAOA P21397 1/20 0.41
HSD17B3 P37058 1/20 0.41
SORD Q00796 1/20 0.41
MCL1 Q07820 1/20 0.38
TNF P01375 1/20 0.38
NOD2 Q9HC29 1/20 0.38
NOD1 Q9Y239 1/20 0.38
WEE1 P30291 1/20 0.37
GPR84 Q9NQS5 1/20 0.36
ALDH1A1 P00352 2/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10028126 0.88 CYP1A2 (0.38) CYP1A2CYP1B1CYP1A1MAOBAKR1B1
SCHEMBL10028128 0.84 GSTP1 (0.41) CYP1A2CYP1B1CYP1A1GPR84ALDH1A1
SCHEMBL10028132 0.80 CYP1A2 (0.35) CYP1A2CYP1B1CYP1A1MAOBAKR1B1
SCHEMBL10028135 0.80 PDE4A (0.46) CYP1A2CYP1B1CYP1A1MAOBAKR1B1
SCHEMBL10028111 0.79 WEE1 (0.42) CYP1A2CYP1B1CYP1A1MAOBAKR1B1
SCHEMBL10028198 0.78 WEE1 (0.41) CYP1A2CYP1B1CYP1A1MAOBAKR1B1
SCHEMBL10028129 0.78 GPR84 (0.38) CYP1A2CYP1B1CYP1A1MAOBAKR1B1
SCHEMBL13551002 0.77 PDE4A (0.40) CYP1A2CYP1B1CYP1A1MAOBAKR1B1
SCHEMBL10028130 0.77 HPGD (0.39) CYP1A2CYP1B1CYP1A1MAOAGPR84
SCHEMBL10028205 0.77 KDM4E (0.38) CYP1A2CYP1B1CYP1A1MAOBAKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046915-B1 NEW MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2015-12-02 EP disclosed
US-8114531-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2012-02-14 US disclosed
US-8114531-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2012-02-14 US disclosed
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2010-01-21 US disclosed
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES L1CAM, SOD1, SLC40A1 CYP1A2 1150/4885CYP1B1 650/4885CYP1A1 751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.